CBD-Proline Cocrystal Pharmaceutical Formulation
A patent (US Pat. 10,604,467) for a medical CBD L-Proline cocrystal published this week assigned to Artelo Biosciences. A cocrystal can have more desirable properties as a pharmaceutical such as increased bioavailability giving value to this IP asset.
Artelo Biosciences uses biopharmaceutical techniques to develop novel therapeutics designed to act on the endocannabinoid system. Discover other novel publications conveniently categorized and displayed on Magic Number’s Patent Radian‚Ñ¢.
Related Posts
Cannabis Popularity Soars Along With Tests To Detect It
The Duquenois Levine Test is used in the field by law enforcement officers to test for THC presence in a suspected sample. The problem with…
Hound Labs, Cannabix and Vox Heat Up the Marijuana Breathalyzer Market
At the start of April 2021, Patent Forecast® released an insight going over some of the big name competitors getting their foot in the door…
Driving While High? Cannabis Sobriety Testing Heats Up
What’s the future of cannabis innovation? We see things before they happen using our Patent Forecast®. One of those is the development of…